Genomics Market Size, Share & Trends Report

Genomics Market Size, Share & Trends Analysis Report By Deliverables, By Application & Technology (Functional Genomics, Epigenomics), By End Use (Pharma & Biotech Companies), And Segment Forecasts, 2019 - 2025

  • Published Date: Jan, 2019
  • Base Year for Estimate: 2017
  • Report ID: 978-1-68038-188-7
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 120

Industry Insights

The global genomics market size was valued at USD 13.75 billion in 2017 and is anticipated to expand at a CAGR of 9.1% over the forecast period. Growth of genomic data pool from research activities has enabled physicians, biologists, and patients to further investigate the genetic predisposition to certain diseases. Clinical application of this data pool is expected to play a major role in transforming the healthcare system with respect to the provision of more accurate, effective, and reliable disease management solutions.

Although clinical application of genomic data is at a nascent stage, the healthcare and research community are making attempts for effective integration of genetic information into clinical workflows. Several clinical centers, such as Stanford Health Care and other cancer research centers, have begun using the available genomic information to devise personalized treatment regime. This, in turn, helps in bridging the gap between translational research and clinical diagnosis and treatment.

Japan genomics market

Growing implementation of human genetic studies into various public health programs such as consumer wellness programs and population screening, aimed at optimizing preventive care for common chronic diseases will support market growth.

Growing investment by government bodies, funding agencies, and biotechnology companies to accelerate research is anticipated to drive the market further. International funding bodies like NIH and Welcome Trust are engaged in providing funds for genetic studies, which, in turn, is expected to fuel genomic studies across the globe.

One of the most important factors anticipated to impact this market is how much and to what extent the medical community will make the use of available genomic information in personalized medicine. Scientists are combining the data generated from sequencing with diagnostics, which has proven effective in enhancing personalized treatment landscape.

Application & Technology Insights

Generation of large amount of sequencing data has led to a significant growth of functional genomics trend. Development of high-throughput technologies for gene, as well as protein, studies has supported the expansion of this segment. Progress in the industry from studying individual genes to entire genomes and proteomes within a relatively short time frame reflects the segment growth. Integration of high-throughput solutions in functional genomics has offered the possibility of developing efficacious drugs with fewer adverse effects.

Furthermore, use of behavioral genetic tool kits holds a significant potential for evaluation of competing hypotheses regarding modules and peculiarities of particular behavior. Investigation of how individual targets communicate and respond within the molecular networks has helped elaborate functioning of biological processes at a cellular level. Pathway analysis has become an integral aspect in drug development and life sciences research. Research community uses pathway analysis to improve fundamental understanding of cellular and molecular biology. On the other hand, pharmaceutical companies implement network analysis for the development of next-generation therapeutics.

Pathway-based analysis has gained more attention after the emergence of genomics and personalized therapies. This is mainly because genomics and personalized therapies aid in in-depth analysis of the ability to navigate signaling pathways and disease networks. Increasing information on these network analyses can be used to address the challenges faced in developing therapeutics and genetic assays to boost the chance of success in R & D. Several types of biological resources, such as pathway databases, gene annotation databases, and gene ontology, can be effectively used for pathway analysis.

Deliverable Insights

Miniaturization in the instruments used in genomic applications is expected to serve as a fillip for market growth. Advantages offered by these instruments include specificity, sensitivity, and automation for the development of Point-of-Care (PoC) diagnostics. With the maturity in development of microfabrication technology, microfluidic systems can be used for different genomic detections. The major objective of these miniaturized instruments is the development of the PoC device. Moreover, rising usage of impedimetric detection is one of the promising techniques for the instruments. Advancements in circuits and systems are also driving the market with a technical revolution in the omics era.

Uptake of cloud-based solutions, which effectively and robustly manage the parallelization and distribution of input data and user code on a large number of computer nodes supporting the market growth. Cloud computing provides a very clear advantage of performing tasks across different parallel computing nodes and processors coupled with significant reduction in the waiting time. Introduction of cloud computing environment for processing NGS generated data has played a great role as a driving force for the current market. Demand for these services would remain strong with the expansion of the customer base from academic and research centers to CROs and biotech and pharma players.

End-use Insights

With a decrease in sequencing costs and improvements in informatics, genetic solutions are now widely accessible in various sectors ranging from small labs to clinical settings. Key usage segments include pharmaceutical and biotechnology companies, hospitals and clinics, academic and government institutes, clinical research, and other end users. Among these, pharmaceutical and biotechnology companies held the largest share owing to rise in the number of genetic research studies aimed at improving drug discovery process and development of efficacious drugs with fewer adverse effects.

Global genomics market

Moreover, biotechnology companies are using gene editing tools to meet the unmet needs of patients through development of recombinant and genetically engineered products. The others segment that includes Direct-To-Consumers (DTC), agriculture research institutes, and forensic centers is estimated to held the lowest penetration in the market. This is primarily because of less usage of genetic tools within these entities. However, in the coming years, this segment is expected to witness lucrative growth owing to the fact that DTC is receiving significant attention amongst consumers, government, and genomic companies.

Regional Insights

North America held the largest share of the overall market in 2017. Increasing investment on research by government organizations, rising patient awareness, and availability of sophisticated healthcare infrastructure has led to the increased technological advancements in this market. Presence of key companies, such as Affymetrix, Inc.; Bio-Rad Laboratories, Inc.; Agilent Technologies; GE Healthcare; Illumina, Inc.; Cepheid, Inc.; and Danaher Corporation, can also be attributed to its high market share.

Asia Pacific is expected to witness the fastest growth in the coming years. Developing infrastructure in these countries has led to the increased demand for biomarkers for diagnostics purposes. Moreover, rising adoption and awareness about a number of genomics technologies in the emerging countries, such as China and India, for detection, treatment, and prognosis of various genetic disorders including diabetes and cancer will support the region’s development.

There are several interesting human genome sequencing projects being carried out. One of the most recent project is Genome Asia 100K (GA 100K). Under this project, 100,000 Asians genomes will be sequenced and analyzed, which will help accelerate population-specific medical advances and precision medicine.

Genomics Market Share Insights

Major companies include Thermo Fisher Scientific, Inc.; Agilent Technologies; Bio-Rad Laboratories, Inc.; Danaher; BGI; F. Hoffmann-La Roche Ltd.; Illumina, Inc.; Pacific Biosciences; Oxford Nanopore Technologies.; 23andMe, Inc., Foundation Medicine, Inc., and Myriad Genetics, Inc. Companies are offering varied reagents that simplify workflow process. High saturation owing to a wide range of reagents and consumables has led companies into adopting different strategies to sustain in the market.

For instance, in January 2017, BD launched Precise WTA Reagents for accurate and simple quantification of genetic information form single cell analysis. Moreover, in July 2016, SGI-DNA entered into a distribution agreement with VWR. Agilent has also broadened its offering of CRISPR RNA libraries for genome-based research.

Report Scope

Attribute

Details

Base year for estimation

2017

Actual estimates/Historical data

2014 - 2016

Forecast period

2018 - 2025

Market representation

Revenue in USD Million and CAGR from 2018 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, U.K., Germany, Japan, China, Brazil, South Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5-analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of the customization.


Segments Covered in the Report

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global genomics market report on the basis of deliverables, application & technology, end use, and region:

  • Deliverables Outlook (Revenue, USD Million, 2014 - 2025)

    • Products

      • Instruments/Systems

      • Consumables/Reagents

    • Services

      • Core Genomics Services

      • NGS-based Services

      • Biomarker Translation Services

      • Computational Services

      • Others

  • Application & Technology Outlook (Revenue, USD Million, 2014 - 2025)

    • Functional

      • Transfection

      • Real-time PCR

      • RNA Interference

      • Mutational Analysis

      • SNP Analysis

      • Microarray Analysis

    • Epigenomics

      • Bisulfite Sequencing

      • Chromatin Immunoprecipitation (ChIP-Seq)

      • Methylated DNA Immunoprecipitation (MeDIP)

      • High Resolution Melt (HRM)

      • Chromatin Accessibility Assays

      • Microarray Analysis

    • Pathway Analysis

      • Bead-based Analysis

      • Microarray Analysis

      • Real-time PCR

      • Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)

    • Biomarker Discovery

      • Mass Spectrometry

      • Real-time PCR

      • Microarray Analysis

      • Statistical Analysis

      • Bioinformatics

      • DNA Sequencing

    • Others

  • End-use Outlook (Revenue, USD Million, 2014 - 2025)

    • Clinical Research

    • Academic and Government Institutes

    • Hospitals and Clinics

    • Pharmaceutical and Biotechnology Companies

    • Other End Users

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

    • The Middle East and Africa (MEA)

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Multi User (2-5) - $5,950
Enterprise Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified